D-0103-2023 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 18, 2023
- Initiation Date
- December 30, 2022
- Termination Date
- June 21, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78 vials
Product Description
QuadMix Plus (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 20mcg/30mg/2mg/0.2mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide in the USA
Code Information
Lot#: 11182022@1, Exp 1/2/2023; 12012022@9, Exp 1/15/2023; 11142022@8, Exp 12/29/2022; 11292022@10, Exp 1/13/2023